Measuring exhaled nitric oxide in COPD: from theoretical consideration to practical views

Marieann Högman,Hà Pham-Ngoc,Bô Nguyen-Duy,Jens Ellingsen,Thông Hua-Huy,Dinh Van Nguyen,Anh Tuan Dinh-Xuan
DOI: https://doi.org/10.1080/17476348.2024.2433537
2024-11-29
Expert Review of Respiratory Medicine
Abstract:Introduction Chronic obstructive pulmonary disease (COPD) is traditionally perceived as Th1-inflammation, but some patients have Th2-inflammation. A high fraction of exhaled nitric oxide (FE NO ) is seen in asthma with Th2-inflammation, justifying FE NO as a point-of-care biomarker. The use of FE NO in COPD is much less frequent. We aimed to review the evidence in favor of FE NO measurement in COPD and discuss its potential usefulness in clinical settings.
respiratory system
What problem does this paper attempt to address?